Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Reductive Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103224963A reveals a marine strain method for high-purity chiral amines. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable biocatalysis.
Patent CN107286203B details a novel route for chiral Ugi's amine. Discover cost-effective manufacturing and supply chain advantages for Josiphos ligands.
Patent CN105712812A reveals high-efficiency chiral amine synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing processes.
Patent CN119913221A reveals enzymatic route for ACEI intermediates. Offers high stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing supply chains.
Patent CN118291412A reveals a novel Leucine Dehydrogenase for efficient L-Phosphinothricin and L-Phenylglycine synthesis, offering significant cost reduction and supply chain reliability.
Discover a novel synthesis route for trans-4-Boc-aminocyclohexanecarboxylic acid via patent CN113402428A. Achieve >95% stereoselectivity and streamlined manufacturing for peptide drugs.
Patent CN104447791B reveals a low-cost D-biotin preparation method. Discover supply chain advantages and high-purity manufacturing capabilities for global procurement.
Patent CN110551032B details a high-efficiency iridium-catalyzed asymmetric reductive amination method, offering significant cost reduction in agrochemical manufacturing and reliable supply chain solutions.
Patent CN114349648A details a one-step ruthenium-catalyzed reductive amination for high-purity chiral amines, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103224963B reveals marine strain catalysis for high-purity chiral amines. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110577941B reveals mutated enzymes for high-purity chiral amine synthesis, offering cost reduction in pharmaceutical intermediate manufacturing via biocatalysis.
Patent CN104829460A reveals a cost-effective asymmetric reductive amination route for cinacalcet hydrochloride, offering high purity and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN112300047A reveals a novel Ru-catalyzed tandem reductive amination for chiral lactams, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN113106078B reveals novel LaLeuDH mutants enabling 1.5M substrate tolerance and coenzyme-free synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Novel catalytic route for Duvelisib intermediates ensures high purity and scalable production for global pharmaceutical supply chains and cost efficiency.
Patent CN103073456B details a high-purity stereoselective synthesis for rivastigmine intermediates, offering significant cost reduction in API manufacturing and scalable production.
Discover the scalable synthesis of CCR-2 antagonist intermediates via patent CN101160286B. Learn about cost-effective routes and high-purity pharmaceutical manufacturing.
Patent CN118324765A reveals a novel Ir-catalyzed route for Duvelisib, offering cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN106866574A reveals palladium-catalyzed asymmetric reductive amination for high-purity chiral sulfonamides, offering supply chain reliability and cost efficiency.
Patent CN110668976A reveals a novel Ir-catalyzed asymmetric synthesis for (R)-Rivastigmine intermediates, offering superior yield and purity for reliable pharmaceutical supply chains.